The C-terminal tail of the bacterial translocation ATPase SecA modulates its activity by Jamshad, Mohammed et al.
 
 
The C-terminal tail of the bacterial translocation
ATPase SecA modulates its activity
Jamshad, Mohammed; Knowles, Timothy J; White, Scott A; Ward, Douglas G; Mohammed,
Fiyaz; Rahman, Kazi Fahmida; Wynne, Max; Hughes, Gareth W; Kramer, Günter; Bukau,
Bernd; Huber, Damon
DOI:
10.7554/eLife.48385
License:
Creative Commons: Attribution (CC BY)
Document Version
Peer reviewed version
Citation for published version (Harvard):
Jamshad, M, Knowles, TJ, White, SA, Ward, DG, Mohammed, F, Rahman, KF, Wynne, M, Hughes, GW,
Kramer, G, Bukau, B & Huber, D 2019, 'The C-terminal tail of the bacterial translocation ATPase SecA
modulates its activity' Elife, vol. 8, e48385. https://doi.org/10.7554/eLife.48385
Link to publication on Research at Birmingham portal
Publisher Rights Statement:
Checked for eligibility: 05/07/2019
eLife 2019;8:e48385 DOI: 10.7554/eLife.48385
https://elifesciences.org/articles/48385
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 13. Aug. 2019
  1 
 
The C-terminal tail of the bacterial translocation ATPase SecA modulates its activity 1 
 2 
Running title: Regulation of SecA by its C-terminal tail 3 
 4 
Mohammed Jamshad
1,2
, Timothy J. Knowles
1,2
, Scott A. White
2
, Douglas G. Ward
3
, Fiyaz 5 
Mohammed
4
, Kazi Rahman
2
, Max Wynne
2
, Gareth W. Hughes
2
, Günter Kramer
5
, Bernd 6 
Bukau
5
, and Damon Huber
2,
*. 7 
 8 
1
These authors contributed equally to this work 9 
 10 
2
Institute for Microbiology and Infection 11 
School of Biosciences 12 
University of Birmingham 13 
Edgbaston, Birmingham, UK 14 
 15 
3
Institute of Cancer and Genomic Sciences 16 
University of Birmingham 17 
Edgbaston, Birmingham, UK 18 
 19 
4
Institute of Immunology and Immunotherapy 20 
University of Birmingham 21 
Edgbaston, Birmingham, UK 22 
 23 
5
Center for Molecular Biology of Heidelberg University (ZMBH); German Cancer Research 24 
Center (DKFZ), ZMBH-DKFZ Alliance  25 
  2 
 
Heidelberg 26 
Germany 27 
 28 
*To whom correspondence should be addressed: 29 
School of Biosciences 30 
University of Birmingham 31 
Edgbaston 32 
Birmingham B15 2TT 33 
UK 34 
d.huber@bham.ac.uk 35 
  36 
  3 
 
Abstract 37 
In bacteria, the translocation of proteins across the cytoplasmic membrane by the Sec 38 
machinery requires the ATPase SecA. SecA can bind ribosomes and recognise nascent 39 
substrate proteins, but the molecular mechanism of recognition is unknown. We investigated 40 
the role of the C-terminal tail (CTT) of SecA in nascent polypeptide recognition. The CTT 41 
consists of a flexible linker (FLD) and a small metal-binding domain (MBD).  Phylogenetic 42 
analysis and ribosome binding experiments indicated that the MBD interacts with 70S 43 
ribosomes. Disruption of the MBD only or the entire CTT had opposing effects on ribosome 44 
binding, substrate-protein binding, ATPase activity and in vivo function, suggesting that the 45 
CTT influences the conformation of SecA. Site-specific crosslinking indicated that F399 in 46 
SecA contacts ribosomal protein uL29, and binding to nascent chains disrupts this interaction. 47 
Structural studies provided insight into the CTT-mediated conformational changes in SecA. 48 
Our results suggest a mechanism for nascent substrate protein recognition. 49 
 50 
Impact Statement 51 
The interaction of SecA with its substrate proteins is regulated by its evolutionarily conserved 52 
C-terminal tail, which autoinhibits SecA unless SecA binds to the ribosome.   53 
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Introduction 54 
 In Escherichia coli, approximately a quarter of all newly synthesised proteins are 55 
transported across the cytoplasmic membrane by the Sec machinery (Cranford Smith and 56 
Huber 2018). Of these, the majority (~65%) require the activity of SecA for translocation 57 
across the membrane. SecA is an evolutionarily conserved and essential ATPase that is 58 
required for protein translocation in bacteria (Cranford Smith and Huber 2018). The catalytic 59 
core of SecA (amino acids ~1-832 in E. coli) contains five domains (figure 1—figure 60 
supplement 1): nucleotide binding domain-1 (NBD1; amino acids 9-220 & 378-411), the 61 
polypeptide crosslinking domain (PPXD; 221-377), nucleotide binding domain-2 (NBD2; 62 
412-620), the α-helical scaffold domain (HSD; 621-672 & 756-832) and the α-helical wing 63 
domain (HWD; 673-755). Binding and hydrolysis of ATP at the NBD1/NBD2 interface 64 
cause conformational changes in the HSD and HWD, which are required for the translocation 65 
of substrate proteins (Cranford Smith and Huber 2018; Collinson, Corey, and Allen 2015). In 66 
addition, the PPXD undergoes a large conformational change, swinging from a position near 67 
the HWD (the “closed” conformation) to a position near NBD2 (the “open” conformation) 68 
(Zimmer, Nam, and Rapoport 2008; Zimmer and Rapoport 2009; Chen et al. 2015). SecA 69 
binds to substrate protein in the groove formed between the PPXD and the two NBDs, and 70 
the PPXD serves as a “clamp” that locks unfolded substrate proteins into this groove when it 71 
is in the open conformation (Zimmer and Rapoport 2009).  72 
SecA can recognise its substrate proteins cotranslationally. SecA binds to the 73 
ribosome (Huber et al. 2011), and ribosome binding facilitates the recognition of nascent 74 
substrate proteins (Huber et al. 2017; Huber et al. 2011). The binding site for SecA on the 75 
ribosome includes ribosomal protein uL23, which is located adjacent to the opening of the 76 
polypeptide exit channel (Huber et al. 2011). Structural and biochemical studies indicate that 77 
ribosome binding is mediated by two regions in the catalytic core: the N-terminal α-helix 78 
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(Singh et al. 2014) and the N-terminal portion of the HSD (Huber et al. 2011) (figure 1—79 
figure supplement 1). The structure of the SecA-ribosome complex was recently determined 80 
at medium resolution (~11 Å) by cryo-electron microscopy (Singh et al. 2014). However, the 81 
molecular mechanism governing the recognition of nascent substrate proteins is unknown.  82 
In addition to the catalytic core, most SecA proteins contain a relatively long C-83 
terminal tail (CTT; also known as the C-terminal linker (Hunt et al. 2002)), whose function is 84 
not well understood (figure 1A). In E. coli, the CTT (833-901) contains of a small metal 85 
binding domain (MBD; 878-901) and a structurally flexible linker domain (FLD; 833-877). 86 
Although it is not required for protein translocation (Or, Navon, and Rapoport 2002; Or et al. 87 
2005; Fekkes, van der Does, and Driessen 1997), E. coli strains producing a C-terminally 88 
truncated SecA protein display modest translocation defects (Or et al. 2005; Grabowicz, Yeh, 89 
and Silhavy 2013). The MBD coordinates a metal ion (thought to be Zn
2+
) via a conserved 90 
CXCX8C(H/C) motif (Dempsey et al. 2004; Fekkes et al. 1999). In E. coli, the MBD is 91 
required for interaction of SecA with SecB (Kimsey, Dagarag, and Kumamoto 1995; 92 
Breukink et al. 1995; Fekkes, van der Does, and Driessen 1997), a molecular chaperone that 93 
is required for the secretion of a subset of Sec substrate proteins (Randall and Hardy 2002). 94 
Although not all SecA proteins contain an MBD, the MBD is conserved in many species that 95 
do not have a SecB homologue (Dempsey et al. 2004). 96 
In this study, we investigated the role of the CTT in the recognition of nascent 97 
substrate proteins by SecA. Phylogenetic and sequence analysis of the CTT suggested that it 98 
could be involved in binding of SecA to ribosomes, which we confirmed using ribosome 99 
cosedimentation and chemical crosslinking approaches. Strikingly, disruption of the MBD 100 
alone or the entire CTT had opposing effects on multiple activities of SecA, suggesting that 101 
the CTT affects conformation of the catalytic core. Mass spectrometry, x-ray crystallography, 102 
and small-angle x-ray scattering experiments indicated that the FLD is bound in the substrate 103 
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binding groove and affects the conformation of the PPXD. Finally, site specific chemical 104 
crosslinking suggested that binding of the MBD to the ribosome allows full-length SecA to 105 
interact with nascent substrate proteins. Taken together, our results provide insight into the 106 
molecular mechanism underlying nascent substrate recognition by SecA. 107 
 108 
Results 109 
 Evolutionary distribution of the MBD of SecA. To investigate the evolutionary 110 
distribution of the CTT, we analysed the sequences of 156 SecA proteins from bacterial 111 
species in 155 phylogenetic families using ClustalOmega (McWilliam et al. 2013). The 112 
phylogenetic tree produced by this analysis generally placed SecA proteins from more closely 113 
related species (e.g. those in the same phylogenetic class) into similar groups (figure 1B; 114 
supplementary files 1 and 2). The majority of SecA proteins (143) contained a CTT (figure 115 
1B, red and black branches). Of these, 117 contained an MBD (figure 1B, black 116 
branches). A small minority (13) lacked the CTT entirely (figure 1B, yellow branches). Of 117 
the 69 SecA proteins from species that contained a SecB homologue (figure 1B, starred 118 
species), only two lacked an MBD. The strong co-conservation of the MBD and SecB 119 
suggests that there is strong selective pressure to maintain the MBD in species possessing 120 
SecB, consistent with previous studies indicating that the MBD is required for binding of 121 
SecA to SecB (Fekkes, van der Does, and Driessen 1997; Fekkes et al. 1999; Zhou and Xu 122 
2003; Randall et al. 2004). However, a significant number of species that lack SecB (52) also 123 
contain a SecA protein with an MBD. Furthermore, many of the residues implicated in SecB 124 
binding were strongly conserved in these MBDs (figure 1C, arrowheads) (Zhou and Xu 125 
2003). These results suggested that the MBD has an evolutionarily conserved function in 126 
addition to its role in binding to SecB. 127 
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 Binding of the CTT to the ribosome. Many of the most highly conserved residues in 128 
the MBD consensus sequence (including in species that lack SecB) are positively charged 129 
and surface exposed (figure 1C), which suggested that the MBD could bind to the negatively 130 
charged surface of the ribosome. A fusion between the small ubiquitin-like modifier (SUMO) 131 
from Saccharomyces cerevisiae and the CTT of E. coli SecA (SUMO-CTT) co-sedimented 132 
with ribosomes through a sucrose cushion during ultracentrifugation, indicating that the CTT 133 
binds to ribosomes (figure 1D, lanes 2 & 4). A shorter protein fusion containing only the 134 
MBD (SUMO-MBD) also cosedimented with ribosomes (figure 1—figure supplement 2), 135 
indicating that the MBD is responsible for this ribosome binding activity, and modification of 136 
the metal-coordinating cysteines with AMS disrupted the ability of SUMO-CTT to 137 
cosediment with ribosomes (figure 1D, lanes 3 & 5). Incubation of SUMO-CTT with 138 
ribosomes in the presence of 5 mM and 25 mM EDC (a non-specific crosslinking agent) 139 
resulted in the appearance of several crosslinking products. These products cross-reacted with 140 
antibodies against uL23 and SecA (figure 1E), suggesting that the CTT binds in the vicinity 141 
of the opening of the polypeptide exit tunnel similar to full-length SecA.   142 
Effect of C-terminal truncations on the affinity of SecA for ribosomes. We next 143 
determined the affinity of C-terminal truncation variants of SecA for the ribosome using 144 
fluorescence anisotropy (Huber et al. 2011) (figure 2A and table 1). The equilibrium 145 
dissociation constant (KD) of the complex between full-length SecA and ribosomes was  ~ 146 
640 nM, similar to previously published figures (figure 2A and table 1) (Huber et al. 2011). 147 
Truncation of the C-terminal 69 amino acids of SecA (SecAΔCTT) caused a modest, but 148 
reproducible, increase in the KD of the SecA-ribosome complex (920 nM) (figure 2A and 149 
table 1). However, truncation of the C-terminal 21 amino acids (SecAΔMBD) significantly 150 
increased the affinity of SecA for the ribosome (KD = 160 nM) (figure 2A and table 1). 151 
  8 
 
These differences in affinity were sufficient to affect the amount of SecA that cosedimented 152 
with ribosomes during ultracentrifugation (figure 2B, lanes 4-6). 153 
Effect of truncations on affinity of SecA for nascent polypeptides. To investigate 154 
whether the truncations affected the affinity of SecA for nascent chains, we examined binding 155 
of SecAΔMBD and SecAΔCTT to ribosome nascent chain complexes (RNCs) containing 156 
arrested nascent SecM. SecM is a model nascent SecA substrate protein (Huber et al. 2017; 157 
Huber et al. 2011). Similar to full-length SecA (Huber et al. 2011), binding of SecAΔMBD 158 
and SecAΔCTT to non-translating ribosomes was sensitive to high concentrations of salt in 159 
the binding buffer (figure 2B, lanes 7-9). Binding of SecA and SecAΔCTT to ribosomes in 160 
the presence of 250 mM potassium acetate was stabilised by the presence of arrested nascent 161 
SecM (figure 2B, lanes 10 & 12). However, nascent SecM did not stabilise binding of 162 
SecAΔMBD to RNCs under the same conditions (figure 2B, lane 11). These results 163 
suggested that SecAΔMBD is defective for binding to nascent substrate protein. 164 
Site-specific crosslinking of SecA to ribosomes. To investigate binding of SecA to 165 
the ribosome in more detail, we incorporated p-benzoyl-L-phenylalanine (Bpa) into SecA at 166 
12 positions using nonsense suppression, including positions 56, 260, 299, 399, 406, 625, 167 
647, 665, 685, 695, 748 and 796 (figure 3A & B) (Singh et al. 2014; Huber et al. 2011; Chin 168 
et al. 2002). The side chains of the amino acids at these positions are located on the surface of 169 
SecA that binds to the ribosome (figure 3A). Bpa contains a photoactivatable side chain that 170 
forms covalent crosslinks to nearby molecules containing C-H bonds. In the presence of 171 
purified 70S ribosomes, SecA containing Bpa at positions 399 (SecA
Bpa399
) and 406 172 
(SecA
Bpa406
) produced additional high molecular weight bands in SDS-PAGE, which were 173 
recognised by α-SecA antiserum (figure 3C). Analysis of the high-molecular weight band 174 
produced by SecA
Bpa399
 by mass-spectrometry (LC-MS/MS) indicated that it was an adduct 175 
between SecA and ribosomal protein uL29. uL29 is located adjacent to uL23 on the 176 
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ribosomal surface, and both F399 and K406 appear to contact uL29 in the structure of the 177 
SecA-ribosome complex determined by cryo-electron microscopy (figure 3A) (Singh et al. 178 
2014). SecA containing Bpa at position 299 also produced a crosslinking adduct that 179 
migrated with a larger apparent molecular weight than the SecA-uL29 adduct (figure 3C). 180 
However, the identity of the crosslinking protein is unknown. SecAΔMBDBpa399 also 181 
produced a high molecular weight crosslinking adduct in the presence of ribosomes, and LC-182 
MS/MS confirmed the presence of both SecA and uL29 in the band (figure 3D), indicating 183 
SecAΔMBD binds to ribosomes at the same site as full-length SecA. 184 
Crosslinking of SecA and SecAΔMBD to RNCs. To investigate the effect of a 185 
nascent chain on binding of SecA to the ribosome, we incubated SecA
Bpa399
 with RNCs 186 
containing arrested nascent SecM or maltose binding protein (MBP) (figure 3D and figure 187 
3—figure supplement 1). The presence of a nascent chain long enough to interact with SecA 188 
inhibited crosslinking of SecA
Bpa399
 to uL29, but the presence of an arrested nascent chain 189 
that is too short to interact with SecA did not significantly affect crosslinking to uL29 (figure 190 
3—figure supplement 2). These results suggest that binding to nascent polypeptide causes a 191 
conformational change in SecA, which affects its interaction with the ribosome. In contrast, 192 
the presence of nascent substrate protein did not affect crosslinking of SecAΔMBD Bpa399 to 193 
uL29 (figure 3D), consistent with the inability of SecAΔMBD to bind to nascent chains. 194 
Effect of truncations on affinity for free polypeptides. We next examined the 195 
affinity of SecA, SecAΔMBD and SecAΔCTT for free polypeptide. To this end, we 196 
determined the affinity of SecA for a short peptide, VipB, which was labelled with an 197 
environmentally sensitive fluorophore (IAANS-VipB; (Pietrosiuk et al. 2011)) that produces 198 
an increase in fluorescence upon binding to SecA. The affinities of SecA and SecAΔCTT for  199 
IAANS-VipB (KD = 0.9 μM and 1.7 μM, respectively) were consistent with the previously 200 
reported affinity of SecA for unfolded substrate protein (Gouridis et al. 2009) (figure 2C and 201 
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table 1). However, the affinity of SecAΔMBD for IAANS-VipB was significantly lower (KD 202 
= 5.9 μM). Furthermore, alanine substitutions in two of the metal-coordinating cysteines 203 
(SecA
C885A/C887A
) greatly reduced the affinity of SecA for IAANS-VipB (table 1), suggesting 204 
that disrupting the structure of the MBD was sufficient to cause this decrease in affinity. 205 
Effect of truncations on the ATPase activity of SecA. To investigate the effect of 206 
the truncations on the ATPase activity of SecA, we determined the basal ATPase rates of 207 
SecA, SecAΔMBD, SecAΔCTT and SecAC885A/C887A. The ATP turnover rate for full-length 208 
SecA was 0.05 s
-1 
(table 1), consistent with previously reported figures (Huber et al. 2011). 209 
Deletion of the entire CTT caused a >10-fold increase in the basal ATPase activity compared 210 
to the full-length protein (0.9 s
-1
) (table 1), suggesting that the FLD inhibits the ATPase 211 
activity of SecA. SecAΔMBD and SecAC885A/C887A did not hydrolyse ATP at a detectable rate, 212 
suggesting that the MBD is required to relieve the FLD-mediated autoinhibition.  213 
Effect of truncations on the folding of SecA. We next investigated the effect of the 214 
C-terminal truncations on the secondary structure content and thermal stability of SecA using 215 
circular dichroism (CD) spectroscopy. The CD spectra of the three proteins indicated that 216 
they were fully folded (figure 2—figure supplement 1). However, the denaturation midpoint 217 
temperature (TM) of SecAΔMBD (42°C) was ~1.5°C higher relative to that of the full-length 218 
protein and ~2°C higher than that of SecAΔCTT (figure 2—figure supplement 2), 219 
suggesting that SecAΔMBD was more stably folded than SecA or SecAΔCTT. 220 
SecA truncation variants have differing abilities to complement the growth 221 
defect of a ΔsecA mutation. To investigate the effect of the C-terminal truncations on the 222 
function of SecA in vivo, we constructed strains in which the sole copy of the secA gene 223 
produced SecA, SecAΔMBD or SecAΔCTT under control of an IPTG-inducible promoter. 224 
Because SecA is required for viability, growth of these strains was dependent on the activity 225 
of the SecA variant in vivo. All three proteins complemented the viability defect of ΔsecA 226 
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mutant (figure 2D) in an IPTG-dependent fashion and produced similar amounts of SecA 227 
(figure 2—figure supplement 3), indicating that the truncated proteins were functional in 228 
vivo. SecAΔCTT and SecAΔMBD were not viable when incubated at room temperature, 229 
consistent with the cold-sensitive growth defect of secB mutant strains (Shimizu, Nishiyama, 230 
and Tokuda 1997). However, cells producing SecAΔMBD grew poorly even at the 231 
permissive temperature (figure 2D), consistent with the idea that truncation of the MBD 232 
alone inhibited the activity of SecA. 233 
Autocrosslinking of the FLD in the substrate binding groove of SecA. In order to 234 
affect such a range of activities of SecA, we reasoned that the CTT likely interacts with the 235 
catalytic core. To investigate this possibility, we incorporated Bpa into the CTT at positions 236 
852, 893 and 898. In order to distinguish between early termination products and full-length 237 
SecA, we fused a short polypeptide tag to the C-terminus of SecA, which causes SecA to be 238 
biotinylated in vivo (SecA-biotin) (Tagwerker et al. 2006; Huber et al. 2011). In addition, we 239 
fused hexahistidine-tagged SUMO to the N-terminus of SecA. Ni-affinity purified protein 240 
containing Bpa at position 852 (SecA
Bpa852
-biotin) migrated more rapidly than the other 241 
proteins in SDS-PAGE (figure 4A), and purified SecA
Bpa852
-biotin interacted with 242 
streptavidin indicating it contains the C-terminal biotin (figure 4B). In addition, purification 243 
of SecA
Bpa852
-biotin from cell lysates by the C-terminal biotin tag yielded proteins that 244 
migrated with molecular weights consistent with full-length SecA-biotin and the faster-245 
migrating species (figure 4—figure supplement 1). These results were consistent with the 246 
notion that the faster migrating SecA
Bpa852
-biotin species was the result of an internal 247 
crosslink within the protein and not early termination at position 852. The chemical basis for 248 
the high efficiency of crosslinking is unknown. However, several possible explanations are 249 
treated in the Discussion section. Purified SecA
Bpa852
-biotin had a very low affinity for 250 
  12 
 
substrate protein and no detectable ATPase activity (table 1), suggesting that SecA
Bpa852
-251 
biotin occupies a conformation similar to that of SecAΔMBD.  252 
To investigate the site of the internal crosslink, we determined the molecular weights 253 
of the tryptic peptides of SecA
Bpa852
-biotin using mass spectrometry (MALDI-TOF). Tryptic 254 
fragments with masses greater than 860 Da were resolvable in the mass spectrum of both full-255 
length SecA-biotin and SecA
Bpa852
-biotin (supplementary file 3). Only one peptide in this 256 
size range, corresponding to amino acids 168-188, was absent from both spectra. As 257 
expected, the tryptic peptide containing position 852 (851-877) was absent from the mass 258 
spectrum of SecA
Bpa852
-biotin but not SecA-biotin. The only peptide absent from SecA
Bpa852
-259 
biotin spectrum but present in wild-type SecA-biotin was the peptide corresponding to amino 260 
acids 361-382 (figure 4C and supplementary file 3). These results suggested that position 261 
852 likely crosslinked to the region of SecA containing amino acids 361-382.  Despite 262 
repeated attempts, the crosslinking adduct between peptides 851-877 and 361-382 was not be 263 
detected. However, the crosslinking adduct is very large and likely consists of a 264 
heterogeneous mixture of crosslinked peptides in different conformations. Both of these 265 
possibilities could have complicated detection of the adduct by mass spectrometry. Amino 266 
acids 361-382 are located in one of the two strands linking the PPXD to NBD1 in the groove 267 
where SecA binds to substrate protein (figure 4D) (Cranford Smith and Huber 2018). 268 
Crosslinking of Bpa at 852 to this peptide would be consistent with previous work suggesting 269 
that the FLD binds in the substrate-binding groove (Hunt et al. 2002; Gelis et al. 2007).  270 
Structural analysis of the SecA truncation variants. We next determined the 271 
crystal structure of SecAΔMBD at 3.5Å resolution (6GOX; figure 5A and supplementary 272 
file 4). SecAΔMBD crystallised as a symmetric dimer in a head-to-tail configuration (figure 273 
5A). This structure was similar to that reported for the E. coli SecA homodimer in complex 274 
with ATP (Papanikolau et al. 2007) (PDB file 2FSG), except that (i) the PPXD is better 275 
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resolved in 6GOX and (ii) the 6GOX dimer is symmetric and the 2FSG dimer is not. 276 
Consistent with previous studies, the structure of the PPXD was less well defined relative to 277 
the other domains of the catalytic core, consistent with the idea that the PPXD is structurally 278 
mobile (Zimmer and Rapoport 2009; Gold et al. 2013).  However, because the FLD was not 279 
resolved, its effect on the structure of SecA could not be determined.  280 
To investigate how the CTT affects the conformation of SecA in solution, we 281 
determined the structures of SecA, SecAΔCTT and SecAΔMBD using small-angle x-ray 282 
scattering (SAXS) (supplementary file 5). The SAXS spectra for all three proteins were 283 
similar in the low-q region, indicating that the overall shapes of the three proteins were 284 
similar, and the radii of gyration suggested that they were dimeric, consistent with previous 285 
studies (Woodbury, Hardy, and Randall 2002) (figure 5—figure supplement 1). However, 286 
the spectra of the proteins diverged in the mid-q region (figure 5—figure supplement 1, 287 
arrow), indicating that there were differences in domain organisation. SecA has been 288 
crystallised in several distinct dimer configurations. The physiological configuration of the 289 
dimer and its relevance is an issue of on-going dispute (see discussion in Cranford Smith and 290 
Huber (2018)). However, fitting of structural models of the E. coli SecA dimer based on PDB 291 
files 2FSG (Papanikolau et al. 2007), 2IBM (Zimmer, Li, and Rapoport 2006), 1M6N (Hunt 292 
et al. 2002), 1NL3 (Sharma et al. 2003), 2IPC (Vassylyev et al. 2006) and 6GOX indicated 293 
that under the experimental conditions, the conformation of the dimer was similar to that 294 
found in 2FSG (χ2 = 3.66) and 6GOX (χ2 = 5.25) (supplementary file 6).  295 
To gain insight into the structural differences between the three proteins, we modelled 296 
the SAXS data by structural fitting. Because initial fitting runs indicated that the CTT was in 297 
close proximity to the catalytic core in models of full-length SecA and SecAΔMBD, we fixed 298 
the position of the FLD in subsequent fits so that it was consistent with the Bpa crosslinking 299 
results. The resulting models suggested that the PPXD was positioned considerably closer to 300 
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NBD2 (i.e. more “open”) in SecA and SecAΔMBD than in SecAΔCTT (p = 2.0 X 10-5 and 301 
1.1 X 10
-7
, respectively) (figure 5F). In models of SecAΔMBD and SecAΔCTT, the PPXDs 302 
in the two protomers of the dimers were positioned asymmetrically (p = 1.8 X 10
-8
 and 303 
0.0085, respectively) (figure 5B-D, F). Finally, in models of full-length SecA, the MBD was 304 
positioned between NBD2 and the C-terminal portion of the HSD (amino acids 756-832) in 305 
both protomers of the dimer (figure 5E). Localisation of the MBD to this region would 306 
position it directly adjacent to the ribosome-binding surface on the catalytic core (Huber et al. 307 
2011; Singh et al. 2014).   308 
  309 
Discussion 310 
 Our results indicate that the CTT controls the conformation of SecA and regulates its 311 
activity. Disruption of the MBD alone (i) increases the affinity of SecA for the ribosome, (ii) 312 
decreases the affinity of SecA for substrate protein, (iii) inhibits the ATPase activity of SecA, 313 
(iv) increases the thermal stability of SecA, (v) prevents SecA from undergoing a 314 
conformational change upon binding to nascent substrate protein and (vi) causes a defect in 315 
SecA function in vivo. However, disruption of both the MBD and the FLD results in a protein 316 
that behaves very similarly to full-length SecA, indicating that the FLD mediates these 317 
effects. Chemical crosslinking and structural modelling of the SAXS data for wild-type SecA 318 
suggest that the FLD interacts with the catalytic core (potentially binding in the substrate 319 
protein binding groove) and causes a conformational change in the PPXD. Gold et al. (2013) 320 
have suggested that opening of the PPXD when SecA is bound to substrate protein (i.e. 321 
enclosing the substrate protein within the binding groove by the PPXD clamp) activates the 322 
ATPase activity of SecA. Our work suggests that enclosure of the FLD by the PPXD has the 323 
opposite effect—that is, autoinhibition of SecA.  324 
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We propose that the MBD is the key for unlocking this autoinhibited conformation in 325 
the full-length protein. Previous work suggests that interaction of the MBD with SecB 326 
increases the affinity of SecA for polypeptides (Gelis et al. 2007). Our results raise the 327 
possibility that binding of the MBD to the ribosome activates SecA in a similar fashion. The 328 
absence of the MBD does not cause a strong defect in binding of SecA to ribosomes (indeed, 329 
SecAΔMBD has a higher affinity for ribosomes than full-length SecA and SecAΔCTT), and 330 
our results suggest that binding of the catalytic core to the ribosome would place the MBD in 331 
an ideal position to bind to the ribosomal surface. Thus, although the affinity of the MBD in 332 
isolation for the ribosome is relatively low, binding of the catalytic core could trigger binding 333 
of the MBD to the ribosome in the context of the full-length protein.  334 
Taken together, our results allow us to propose a mechanism for the recognition of 335 
nascent substrate proteins by SecA (figure 6): (i) interaction of the MBD with the ribosomal 336 
surface upon binding of the catalytic core of SecA to the ribosome destabilises the interaction 337 
between the FLD and the catalytic core; (ii) destabilisation of the FLD allows SecA to sample 338 
nascent polypeptides; (iii) the stable interaction of SecA with nascent substrate protein 339 
displaces the FLD from the substrate binding groove; and (iv) binding of SecA to nascent 340 
substrate protein causes a conformational change in SecA that leads to release from the 341 
ribosome. 342 
The physiological role of CTT-mediated autoinhibition is not yet known. One 343 
possibility is that autoinhibition prevents the spurious interaction of SecA with non-substrate 344 
proteins by only allowing it to interact with polypeptides in the presence of its ligands (e.g. 345 
translating ribosomes, SecB and potentially phospholipids/SecYEG) (Breukink et al. 1995; 346 
Gelis et al. 2007; Fekkes et al. 1999). Indeed, overproduction of substrate polypeptides 347 
causes a translocation defect in vivo (Wagner et al. 2007; Muller, Reinert, and Malke 1989; 348 
Oliver and Beckwith 1982), indicating that SecA can be overwhelmed by interactions with 349 
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too many substrate proteins. In addition, the spurious translocation of cytoplasmic proteins 350 
can be toxic (van Stelten et al. 2009; Emr, Schwartz, and Silhavy 1978).  Alternatively, the 351 
structure of the MBD could regulate the activity of SecA in response to physiological stress. 352 
For example, research by the Huber group suggests that the physiological ligand of the MBD 353 
is iron (BIORXIV/2019/613315). It is possible that the structure of the MBD is regulated in 354 
response to iron limitation or the redox state of the bound metal. If so, the partial activity of 355 
SecAΔMBD in vivo suggests that the CTT modulates the activity of SecA rather than 356 
inhibiting it completely. 357 
Our results suggest that SecA
Bpa852
-biotin produces auto-crosslinks very efficiently. 358 
At least three factors could contribute to the high efficiency of auto-crosslinking in 359 
SecA
Bpa852
-biotin: (i) the amount of time the benzophenone group of the Bpa is in contact 360 
with the target molecule, (ii) the chemical reactivity of Bpa toward the target molecule, and 361 
(iii) the amount of time the benzophenone group stays in the activated state. First, the results 362 
of this study and others (Gelis et al. 2007) is consistent with the idea that the FLD is stably 363 
bound in the substrate protein-binding groove of SecA, which should result in a long-lived 364 
contact between position 852 and the amino acids lining the substrate binding groove. 365 
Second, although benzophenone can, in theory, react with any C-H bond, in practice it reacts 366 
with different efficiencies toward different amino acid side chains (Wittelsberger et al. 2006; 367 
Lancia et al. 2014). Finally, the chemical environment surrounding a benzophenone group 368 
(e.g. hydrophobicity, pH, etc.) can influence its photo-reactive properties (Barsotti et al. 369 
2015; Barsotti et al. 2017). Because Bpa is typically incorporated at surface-exposed 370 
positions in order to capture protein-ligand interactions, these environmental effects are 371 
normally negligible. However, the hydrophobic environment surrounding the side chain of 372 
position 852 when bound in the substrate binding groove could have a significant effect on its 373 
reactivity. 374 
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The basic features of the catalytic core of SecA are highly conserved amongst 375 
bacteria, but different bacterial species contain a diverse array of loops and extensions. For 376 
example, our phylogenetic analysis indicated that many species contain alternative CTTs with 377 
structures that are significantly different from that of E. coli. These differences could allow 378 
SecA to be regulated in response to interaction with a different subset of interaction partners. 379 
Nonetheless, many of these alternative CTTs are highly positively charged (e.g. those of 380 
many Actinobacteria), suggesting that they may retain the interaction with the ribosome. 381 
Some phylogenetic groups (e.g. the Cyanobacteria) lack a CTT entirely. However, most of 382 
these species contain large loops in between the conserved elements of the catalytic core of 383 
the protein. Indeed, E. coli SecA also contains a “variable” subdomain in NBD2 (amino acids 384 
~519-547), which has been proposed to regulate its activity (Das et al. 2012). It is possible 385 
that the large loops in between the conserved features of the catalytic core could function 386 
analogously to the CTT in E. coli SecA. 387 
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 390 
Chemicals and media. All chemicals were purchased from Sigma-Aldrich (St. Louis, 391 
MO, USA) unless otherwise indicated. Anti-thioredoxin-1 antiserum was purchased from 392 
Sigma-Aldrich. Rabbit anti-SecA antiserum was a laboratory stock. Sheep anti-uL23 393 
antiserum was a kind gift from R. Brimacombe. IR700-labelled anti-rabbit and IR800-394 
labelled anti-sheep antibodies were purchased from Rockland (Philadelphia, PA). 395 
Horseradish peroxidase (HRP)-labelled anti-rabbit antibody was purchased from GE 396 
Healthcare. HRP-coupled streptactin was purchased from IBA Lifesciences (Goettingen, 397 
Germany). Bpa was purchased from Bachem (Santa Cruz, CA). Strains were grown in 398 
lysogeny broth (LB) containing kanamycin (30 μg/ml) or ampicillin (200 μg/ml) as required. 399 
Strains were grown in LB the concentration of IPTG indicated. 400 
Strains and plasmids. Strains and plasmids were constructed using standard methods 401 
(Miller 1992; Sambrook and Russell 2001). For protein-expression plasmids, the DNA 402 
encoding full-length SecA or fragments of SecA were amplified by PCR and ligated into 403 
plasmid pCA528 (His6-SUMO) or pCA597 (Strep3-SUMO) using the BsaI and BamHI 404 
restriction sites(Andreasson et al. 2008). UAG stop codons were introduced into plasmids 405 
expressing His-SUMO-SecA or His-SUMO-SecA-biotin using QuikChange (Agilent). 406 
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Plasmid pSup-Bpa-6TRN was a kind gift from P. Schultz. Strains DRH1119, DRH1120 and 407 
DRH1121 were constructed by cloning secA genes producing full-length SecA, SecAΔMBD 408 
and SecAΔCTT into pDSW204 (Weiss et al. 1999) and then introducing them onto the 409 
chromosome strain DRH663 (MC4100 ΔsecA::KanR + pTrcSpc-secA) (Huber et al. 2011) 410 
using lambda InCh (Boyd et al. 2000). The SecA-producing plasmid in the resulting strain 411 
was then cured by plating on LB containing 1 mM isopropyl-thiogalactoside (IPTG). All 412 
three strains required > 10μM IPTG for growth on LB.  413 
Phylogenetic analysis. The sequences of SecA for the given UniProtKB entry 414 
names(The UniProt 2017) were analysed using ClustalOmega(McWilliam et al. 2013). The 415 
unrooted phylogenetic tree was rendered using iTOL(Ciccarelli et al. 2006). The logo of the 416 
consensus MBD sequence was generated using WebLogo 417 
(https://weblogo.berkeley.edu/logo.cgi).  418 
Ribosome and protein purification. Ribosomes and arrested RNCs were purified as 419 
previously described (Rutkowska et al. 2008; Huber et al. 2011). SecA was purified as 420 
described previously (Huber et al. 2017). BL21(DE3) (laboratory stock) or BL21(DE3) 421 
containing plasmid pSup-Bpa-6TRN (Chin et al. 2002) was transformed with the appropriate 422 
plasmid and grown in LB in the presence of kanamycin at 37°C to OD600 ~1, induced using 1 423 
mM IPTG and shifted to 18°C overnight. Cells were then harvested by centrifugation and 424 
lysed by cell disruption in buffer 1 (50 mM K·HEPES, pH 7.5, 500 mM NaCl and 0.5 mM 425 
TCEP [tris(2-carboxyethyl)phosphine]) containing cOmplete EDTA-free protease inhibitor 426 
cocktail (Roche). Unlabelled His-tagged proteins were affinity purified by passing over a 5 427 
ml Ni-NTA HiTrap column (GE Healthcare), washed with buffer containing 50 mM 428 
imidazole and eluted from the column in buffer containing 250 mM imidazole. The eluted 429 
protein was cleaved with the SUMO-protease Ulp1 and the SUMO moiety was removed by 430 
passing over a 5 ml Ni-NTA HiTrap column. The partially purified protein was then 431 
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concentrated (Centricon) and purified by size exclusion chromatography using a sepharose S-432 
200 column (GE Healthcare). Bpa-labelled proteins were purified as described by Huber et 433 
al. (2017). For Strep-tagged proteins, lysates from cells producing SUMO-CTT and SUMO-434 
MBD were passed over streptactin-coupled sepharose beads (IBA Lifesciences), washed 435 
extensively with buffer 2 (20 mM K·HEPES, pH 7.5, 100 mM potassium acetate, 10 mM 436 
magnesium acetate) and eluted using buffer 2 containing 10 mM desthiobiotin. SUMO-CTT 437 
was modified with 4-acetamido-4′-maleimidylstilbene-2,2′-disulfonic acid (AMS) by 438 
incubating 75 μM SUMO-CTT with 500 μM AMS in buffer 2 for 30 minutes on ice. AMS 439 
labelling was terminated by the addition of 500 μM β-mercaptoethanol. Efficient labelling 440 
was confirmed by the increased mobility of the modified protein in SDS-PAGE. For 441 
purification of SUMO-SecA
Bpa852
-biotin by its C-terminal biotin tag, lysates of cells 442 
producing SUMO-SecA-biotin and SUMO-SecA
Bpa852
-biotin were incubated with 50 μl 443 
hydrophilic streptavidin magnetic beads and washed five times with 1 ml buffer 2. The bound 444 
protein was eluted from the beads by boiling in 50 μl 1X Laemmli buffer and resolved on a 445 
12% BioRad Stain-free Ready gel.  446 
 Western blotting. Western blots were carried out as previously described(Sambrook 447 
and Russell 2001). Protein samples were resolved using “Any kD” SDS-PAGE gels (BioRad) 448 
and transferred to nitrocellulose membranes. Membranes were probed using the indicated 449 
primary and secondary antisera or with HRP-streptactin. For HRP-based detection, 450 
membranes were developed using ECL (GE Healthcare) and visualised using a BioRad Gel-451 
Doc. For IR700- and IR800-based detection, membranes were visualised using a LI-COR 452 
Odyssey scanner.  453 
 Ribosome cosedimentation. Ribosome cosedimentation experiments were carried 454 
out as previously described(Huber et al. 2017). Binding reactions were incubated in buffer 455 
containing 10 mM HEPES potassium salt, pH 7.5, 100 mM potassium acetate, 10 mM 456 
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magnesium acetate, 1 mM β-mercaptoethanol for >10 minutes. The reaction mixture was 457 
then layered on top of a 30% sucrose cushion made with the same buffer and centrifuged at 458 
>200,000 x g for 90 minutes. The supernatant was discarded. The concentration of ribosomes 459 
in the pellet fractions were normalised using the absorbance at 260 nm.   460 
 Fluorescence anisotropy. Determination of the KD of the SecA-ribosome complex 461 
by fluorescence anisotropy was determined as previously described(Huber et al. 2011). SecA, 462 
SecAΔMBD and SecAΔCTT were labelled with Ru(bpy)2(dcbpy) and the fluorescence 463 
anisotropy was determined on a Jasco FP-6500 fluorometer containing an ADP303 464 
attachment using an excitation wavelength of 426 nm (slit width 5 nm) and an emission 465 
wavelength of 640 nm (slit width 10 nm). 466 
CD spectroscopy. The CD spectra of 2µM solutions of full-length SecA, 467 
SecAΔMBD, or SecAΔCTT in 10 mM potassium phosphate buffer (pH 7.5) were measured 468 
at temperatures that promote folding (10°C) and denaturation (85°C) in a 0.1cm cuvette using 469 
a Jasco J750 CD spectrometer.  For thermal titrations, the temperature was raised 0.5 K/min 470 
from 30 to 50°C and circular dichroism was measured at 222 nm. 471 
 Peptide binding. 600 nM VipB peptide labelled with IAANS(Pietrosiuk et al. 2011) 472 
was incubated with increasing concentrations of SecA or the indicated SecA variant. The 473 
increase in IAANS fluorescence upon binding of SecA was measured using a Jasco FP-6500 474 
fluorometer or a BMG Labtech CLARIOStar. 475 
ATPase assays. ATPase activities were determined by measuring the rate of NADH 476 
oxidation in a coupled reaction(Kiianitsa, Solinger, and Heyer 2003). 1μM SecA, or the 477 
respective SecA variant, was added to a solution containing 250 mM NADH, 0.5 mM 478 
phosphoenolpyruvate, 2 mM ATP, 20/ml lactate dehydrogenase, 100 U/ml pyruvate kinase 479 
and incubated at 25°C, 50 mM K·HEPES, pH 7.5 and 500 mM NaCl. The decrease in 480 
absorbance at 340 nm from the oxidation of NADH to NAD
+ 
was measured using an Anthos 481 
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Zenyth 340rt (Biochrom) absorbance photometer equipped with ADAP software. The rate of 482 
ATP hydrolysis was determined from the rate of NADH oxidation by dividing the rate of 483 
decrease in the absorbance by the extinction coefficient for NADH (6220 M
-1
 cm
-1
). 484 
 Chemical crosslinking. Non-specific crosslinking of SUMO-CTT to the ribosome 485 
using 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) were carried out as described 486 
previously (Huber et al. 2011). Site specific crosslinking of SecA containing Bpa was carried 487 
out as described by Huber et al. (2017). 488 
 Mass spectrometry. Auto-crosslinked samples were digested with sequencing grade 489 
trypsin and the masses of the tryptic peptides were determined using MALDI-TOF mass 490 
spectrometry. The identity of ribosomal crosslinking adducts was determined by excising the 491 
protein band from a Coomassie-stained gel and analysing the tryptic peptide fragments using 492 
liquid chromatography-tandem mass spectrometry (LC-MS/MS) identification (The 493 
Advanced Mass Spectrometry Facility, School of Biosciences, University of Birmingham). 494 
X-ray crystallography. SecAΔMBD was crystallised by mixing 2 μl of purified 495 
protein (100 μM) with 2 μl of a 9:1 mixture of PEG/Ion 2 Screen # 39 buffer (0.04M Citric 496 
acid, 0.06M BIS-TRIS propane,  pH6.4, 20% Polyethylene glycol 3,350) (Hampton 497 
Research, Aliso Viejo, CA, USA) and Morpheus condition 47, box 2 (0.1M Amino acids, 498 
0.1M Buffer system 3, pH 8.5, 50% v/v Precipitant Mix 3) (Molecular Dimensions, 499 
Newmarket, UK) in a 48-well MRC MAXI plate (Molecular Dimensions, Newmarket, UK). 500 
Crystals appeared within six days and were fully matured by two weeks. Crystals were 501 
analysed at Diamond light source, and the structure was solved by molecular replacement 502 
using PDB file 2FSG at 3.5 Å resolution (Table S1). The structure was deposited at RCSB 503 
under PDB file 6GOX. 504 
SAXS measurements. Synchrotron radiation X-ray scattering data were collected on 505 
the ESRF BM29 BioSAXS beamline (Grenoble) (Table S2). An in-line Superose 6 10/300 506 
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GL column (GE Healthcare) was used to ensure that the protein was free from aggregates and 507 
that it occupied a single oligomeric state during data collection. The sample-to-detector 508 
distance was 3 m, covering a range of momentum transfer s = 0.03-0.494 Å−1 (s = (4π·sin θ)/ 509 
λ, where 2θ is the scattering angle, and λ = 0.992 Å is the X-ray wavelength). Data from the 510 
detector were normalized to the transmitted beam intensity, averaged, placed on absolute 511 
scale relative to water and the scattering of buffer solutions subtracted. All data 512 
manipulations were performed using PRIMUSqt and ATSAS(Petoukhov et al. 2012). The 513 
forward scattering I(0) and radius of gyration, Rg were determined by Guinier analysis. These 514 
parameters were also estimated from the full scattering curves using the indirect Fourier 515 
transform method implemented in the program GNOM, along with the distance distribution 516 
function p(r) and the maximum particle dimensions Dmax. Molecular masses of solutes were 517 
estimated from SAXS data by comparing the extrapolated forward scattering with that of a 518 
reference solution of bovine serum albumin. Computation of theoretical scattering intensities 519 
was performed using the program CRYSOL. 520 
Molecular modelling of SAXS data. SAXS data has been deposited at the SASBDB 521 
(www.sasbdb.org) with accession codes: SASDDY9 (full-length SecA), SASDDZ9 522 
(SecAΔMBD) and SASDE22 (SecAΔCTT). For modelling based on SAXS data, multiple fits 523 
were performed to verify the stability of the solution, and to establish the most typical 3D 524 
reconstructions using DAMAVER. Guinier analysis of the SAXS data indicated that the 525 
protein was dimeric under the conditions used for SAXS. Structural models of the E. coli 526 
SecA dimer were generated by aligning the structure of SecA in PDB file 2VDA to PDB files 527 
2FSG, 2IBM, 2IPC, 1M6N, 1NL3 and 6GOX using PyMol v. 1.8.0.5 and refining using 528 
GROMACS (Pronk et al. 2013). Because the CTT is not resolved in the structures used for 529 
modelling, these models were fitted to the SAXS spectrum of SecAΔCTT using FoXS 530 
(Schneidman-Duhovny et al. 2016) (supplemental table S3). The structures of full-length 531 
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SecA, SecAΔMBD and SecAΔCTT were modelled by fitting the 2FSG dimer to the 532 
respective SAXS data by multi-step rigid body refinement using CORAL (Petoukhov et al. 533 
2012). The positions of NBD1, NBD2, HSD and HWD were fixed in all models. The regions 534 
corresponding to residues 1-8, 220-231, 367-375 were defined as linkers and modelled as 535 
flexible. The PPXD was allowed rigid body movement in all three models. The FLD 536 
(residues 829-832 in SecAΔCTT and 829-880 in SecAΔMBD and full-length SecA) were 537 
modelled as flexible. For full length SecA, the MBD was modelled using PDB file 1SX0 and 538 
allowed rigid-body movement. Because initial modelling indicated that the FLD was in close 539 
contact with the catalytic core, and because photocrosslinking indicated the FLD was bound 540 
in the substrate binding groove, residues 851-854 were modelled to form a small β-sheet with 541 
residues 222-225 and 373-375 and allowed rigid body movement. All ten independently 542 
generated fits for SecA and SecAΔMBD produced plausible structural models (χ2 = 0.97 ± 543 
0.02 and 1.87 ± 0.09, respectively). Ten of 15 of the fits of SecAΔCTT produced plausible 544 
structural models (χ2 = 1.82 ± 0.18). In the remaining five fits, the position of the PPXD in 545 
one of the two protomers was inconsistent with previously published structures of SecA and 546 
occupied a non-realisitic conformation, suggesting increased mobility of the PPXD in 547 
SecAΔCTT. 548 
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Table 1. Biochemical properties of wild-type and mutant SecA proteins 724 
SecA variant KD 
Ribosomes
a
 
KD 
VipB
b 
Basal ATPase 
activity
c 
TM
d 
Wild type 640 ± 33 nM 0.9 μM 0.053 ± 0.02 s-1 40.7 ± 0.09 
°C 
SecAΔMBD 160 ± 35 nM 1.7 μM < 0.001 s-1 42.0 ± 0.08 
°C 
SecAΔCTT 920 ± 38 nM 5.9 μM 0.91 ± 0.02 s-1 40.0 ± 0.1 °C 
SecA
C885A/C887A 
ND
e
 >10 μM < 0.001 s-1 NDe 
SecA
Bpa852 
ND
e
 >10 μM < 0.001 s-1 NDe 
a
Equilibrium dissociation constant of the complex between SecA and non-translating 70S 725 
ribosomes as determined by fluorescence anisotropy. Confidence intervals are the standard 726 
error of the fit. 727 
b
Equilibrium dissociation constant of the complex between SecA and IAANS-labelled VipB 728 
peptide as determined by change in fluorescence. 729 
c
Rate of ATP hydrolysis by SecA in the absence of substrate protein and SecYEG 730 
d
Denaturation midpoint temperature as determined by the change in circular dichroism at 222 731 
nm. 732 
e
not determined  733 
  734 
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Figure legends 735 
Figure 1. Phylogenetic analysis of the CTT and binding of E. coli CTT to the ribosome. 736 
(A) Schematic diagram of the primary structure of SecA, SecAΔMBD and SecAΔCTT. 737 
Structures are oriented with the N-termini to the left, and the amino acid positions of the N- 738 
and C-termini are indicated. Residues of the catalytic core and the CTT are indicated below. 739 
Catalytic core, black; FLD, yellow; MBD, red. (B) Phylogenetic tree of the SecA proteins of 740 
156 representative species from 155 different bacterial families. Species names are given as 741 
the five-letter organism mnemonic in UniProtKB (The UniProt 2017). Taxonimical classes 742 
are colour-coded according to the legend. Leaves representing SecA proteins with an MBD 743 
are coloured black. Those with CTTs lacking a MBD are coloured red, and those that lack a 744 
CTT entirely are coloured yellow. Species that also contain a SecB protein are indicated with 745 
a star (*). (C) Logo of the consensus sequence of the MBD generated from the 117 species 746 
containing the MBD in the phylogenetic analysis. Positions of the metal-coordinating amino 747 
acids are indicated above. Amino acids that contact SecB in the structure of the MBD-SecB 748 
complex (Zhou and Xu 2003) (1OZB) are indicated by arrowheads below. (D) Binding 749 
reactions containing 1 μM ribosomes, 10 μM SUMO-CTT and 10 μM AMS-modified 750 
SUMO-CTT (AMS-SUMO-CTT) were equilibrated at room temperature and layered on a 751 
30% sucrose cushion. Ribosomes were then sedimented through the cushion by 752 
ultracentrifugation. Samples were resolved on SDS-PAGE and probed by western blotting 753 
against the Strep tag using HRP-coupled Streptactin. (E) 10 μM SUMO-CTT containing an 754 
N-terminal Strep(II)-tag was incubated with 1 μM purified ribosomes and treated with 5 mM 755 
or 25 mM EDC, as indicated. Samples were resolved by SDS-PAGE and analysed by western 756 
blotting by simultaneously probing against SecA (red) and ribosomal protein uL23 (green). 757 
The positions of SUMO-CTT, L23 and crosslinking adducts between them (*) are indicated 758 
at left. 759 
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 760 
Figure 2. Effect of C-terminal truncations on SecA function in vitro and in vivo. (A) 900 761 
nM Ru(bpy)2(dcbpy)-labelled SecA (Wild type; circles), SecAΔMBD (ΔMBD; triangles) or 762 
SecAΔCTT (ΔCTT; squares) was incubated in the presence of increasing concentrations of 763 
purified 70S ribosomes. Because error bars corresponding to one standard deviation obscured 764 
the symbols, they were omitted from the graph. The equilibrium dissociation constant (KD) of 765 
the complex was determined by fitting the increase in fluorescence anisotropy from the 766 
Ru(bpy)2(dcbpy) (lines; Table 1). (B) 0.5 μM SecA, SecAΔMBD or SecAΔCTT was 767 
incubated in the absence (lanes 1-3) of ribosomes, in the presence of 0.5 μM vacant 70S 768 
ribosomes (lanes 4-9) or in the presence of 0.5 μM RNCs containing nascent SecM peptide 769 
(lanes 10-12). Where indicated, binding reactions were incubated in the presence of 100 mM 770 
(lanes 1-6) or 250 mM (lanes 7-12) potassium acetate (KOAc). Binding reactions were 771 
layered on a 30% sucrose cushion and ribosomes were sedimented through the sucrose 772 
cushion by ultracentrifugation. Ribosomal pellets were resolved by SDS-PAGE and stained 773 
by Coomassie. (C) 600 nM IAANS-VipB peptide was incubated with increasing 774 
concentrations of SecA (Wild type; circles), SecAΔMBD (ΔMBD; triangles) or SecAΔCTT 775 
(ΔCTT; squares). Confidence intervals represent one standard deviation. The KD for the 776 
SecA-peptide complex was determined by fitting the increase in IAANS fluorescence upon 777 
binding to SecA (lines; table 1). (D) Growth of strains producing SecA (DRH1119; bottom 778 
left), SecAΔMBD (DRH1120; bottom right) and SecAΔCTT (DRH1121; top) on LB plates 779 
containing 100 μM IPTG. 780 
 781 
Figure 3. Site-specific crosslinking of SecA to purified ribosomes and ribosome-nascent 782 
chain complexes. (A & B) Sites of incorporation of Bpa in the structure of E. coli SecA. (A) 783 
Fit of the high resolution structure of SecA (PDB code 2VDA (Gelis et al. 2007)) and the 70S 784 
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ribosome (PDB code 4V4Q (Schuwirth et al. 2005)) to the cryoEM structure of the SecA 785 
ribosome complex (EMD-2565 (Singh et al. 2014)). (B) View of SecA from the ribosome-786 
interaction surface. Amino acid positions where Bpa was incorporated are represented in 787 
space fill (yellow). Positions that crosslink to ribosomal proteins are coloured red. The 788 
locations of the N-terminal α-helix of SecA and of ribosomal proteins uL23 (dark blue), uL29 789 
(purple) and uL24 (cyan) are indicated. Structural models were rendered using Chimera v. 790 
1.12 (Pettersen et al. 2004). (C) Bpa-mediated photocrosslinking of SecA variants to vacant 791 
70S ribosomes. 1 μM purified ribosomes were incubated with 1 μM SecA containing BpA at 792 
the indicated position and exposed to light at 365 nm (above) or incubated in the dark. 793 
Crosslinking adducts consistent with the molecular weight of a covalent crosslink to 794 
ribosomal proteins are indicated with red arrowheads. The positions of full-length SecA and 795 
uncleaved SUMO-SecA protein are indicated to the right. (D) 1 μM SecABpa399 or 796 
SecAΔMBDBpa399 was incubated with 1 μM non-translating 70S ribosomes or 1 μM arrested 797 
RNCs containing nascent SecM (SecM-RNCs) and exposed to light at 365 nm. The positions 798 
of full-length SecA and the SecA-uL29 crosslinking adduct are indicated. In C & D, samples 799 
were resolved using SDS-PAGE and probed by western blotting using anti-SecA antiserum. 800 
LC-MS/MS analysis of the high-molecular weight bands produced by SecA
Bpa399
 and  801 
SecAΔMBDBpa399 in the presence of vacant 70S ribosomes indicated that they contained both 802 
SecA and ribosomal protein uL29. 803 
 804 
Figure 4. Auto-crosslinking of the CTT to the catalytic core of SecA. (A & B) 1 μM 805 
SUMO-tagged SecA-biotin containing Bpa at position 852, 893 or 898 in the CTT was 806 
incubated in the absence (-) or presence (+) of UV light at 365 nm. The protein samples were 807 
resolved using SDS-PAGE and visualised by (A) Coomassie staining or (B) western blotting 808 
against the C-terminal biotin tag. The positions of full-length SUMO-SecA is indicated. (C) 809 
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Mass spectra of wild-type SecA-biotin (above, blue) and SecA
Bpa852
-biotin (below, red) in the 810 
region of 2450-2750 Da region. Wild-type SecA-biotin and SecA
Bpa852
-biotin were exposed 811 
to light at 365 nm and subsequently digested with trypsin. The masses of the tryptic 812 
fragments were determined using MALDI-TOF. (D) Structure of SecA (2VDA(Gelis et al. 813 
2007)). The main body of the catalytic core is coloured blue, the PPXD is coloured cyan and 814 
the tryptic peptide that crosslinks to position 852 (amino acids 361-382) is highlighted in 815 
orange. The structural model was rendered using Chimera v. 1.12 (Pettersen et al. 2004). 816 
 817 
Figure 5. SAXS analysis of SecA truncation variants. (A) X-ray crystal structure of 818 
SecAΔMBD at 3.5Å solved by molecular replacement. The main body of the catalytic core in 819 
the asymmetric unit (Protomer 1) is coloured orange with the PPXD highlighted in cyan. The 820 
crystallographic mate (Protomer 2) interacts with promoter 1 using an interface similar to that 821 
found in 2FSG (Papanikolau et al. 2007), suggesting that this is the dimer interface of the 822 
purified protein in solution. The position of the most C-terminal residue that could be 823 
resolved (proline 834) is noted with an asterisk in the right panel. (B-E) Overlay of 10 824 
independent structural models of SecA (B, C), SecAΔMBD (D) and SecAΔCTT (E) 825 
generated from fitting to the SAXS data using CORAL. The main body of the catalytic core 826 
is coloured grey, and the flexible residues are not displayed. (B, D, E) To facilitate 827 
visualization of the asymmetry in the in the dimeric models, both protomeric partners of the 828 
dimer were overlaid and the PPXD was coloured (blue/magenta) according to the protomer. 829 
The MBD is not displayed in panel B. (C) To facilitate visualization of the position of the 830 
MBD in the full-length protein, both protomeric partners of the dimer were overlaid and the 831 
MBD of the dimer pair that was located nearest to position 596 of the depicted protomer 832 
(orange) was displayed. In panel C, the PPXDs of two protomers, which occupy the same 833 
space as the MBDs, are not displayed. (F) Plot of the position of the PPXD in partners of the 834 
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SecA dimer predicted by structural modelling. The distance between the α-carbon of amino 835 
acid 314, which is located near the centroid of the PPXD, and amino acid 596 in NBD2 was 836 
determined for each protomer and plotted against the distance in the second protomer. SecA, 837 
black circles (FL); SecAΔMBD, orange triangles (ΔMBD); SecAΔCTT, blue squares 838 
(ΔCTT). The grey diagonal line indicates the position of the distances if the dimers were 839 
symmetric. χ2 values to the diagonal were calculated and used to determine p-values to test 840 
whether the asymmetry in the dimer was statistically significant. 841 
 842 
Figure 6. Diagram of the proposed mechanism for recognition of nascent substrate 843 
proteins by SecA. (a) In solution, SecA occupies an autoinhibited conformation with the 844 
FLD bound stably in the substrate protein binding site and the PPXD in the open 845 
conformation. (b) Binding of both the catalytic core and the MBD to the ribosomal surface 846 
causes the PPXD to shift to the open conformation, which destabilises binding of the FLD 847 
and allows SecA to sample nascent polypeptides. (c) Binding to the nascent substrate protein 848 
displaces the FLD from the substrate protein binding site and the PPXD returns to the open 849 
conformation, stabilising this interaction. Binding to nascent substrate releases SecA from the 850 
ribosomal surface. 851 
 852 
Figure supplement legends 853 
Figure 1—figure supplement 1. Structural model of the catalytic core of SecA in the 854 
“closed” conformation. Structural model of E. coli SecA from PDB file 2VDA (Gelis et al. 855 
2007) in ribbon diagram. The model is coloured according to domains described in the main 856 
text. NBD1, dark blue; NBD2 cyan; PPXD, light blue; HSD, red; HWD, orange. The side 857 
chains of lysines 625 (K625) and 633 (K633), which were identified by Huber et al. (2011) to 858 
be involved in ribosome binding, are depicted in space-fill. The N-terminal α-helix (aa1-38), 859 
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which was identified by Singh et al. (2014) to be involved in ribosome binding is coloured 860 
green. The CTT is not resolvable in high-resolution structures of SecA and is therefore not 861 
depicted. 862 
 863 
Figure 1—figure supplement 2. SUMO-MBD cosediments with ribosomes. The C-864 
terminal 27 amino acids of SecA were fused to the C-terminus of Strep-tagged SUMO 865 
(SUMO-MBD). 5 μM SUMO-MBD was incubated in the presence or absence of 1 μM 70S 866 
ribosomes. Binding reactions were layered on a 30% sucrose cushion and subjected to 867 
ultracentrifugation to sediment ribosomes. The pellet fractions were then resolved by SDS-868 
PAGE and analysed by western blotting against the Strep tag. 869 
 870 
Figure 2—figure supplement 1. CD spectra of SecA, SecAΔMBD and SecAΔCTT. Far-871 
UV circular dichroism (CD) spectra of 2 µM solutions of SecA, SecAΔMBD, and 872 
SecAΔCTT in 10mM potassium phosphate (pH 7.5). 873 
 874 
Figure 2—figure supplement 2. Thermal denaturation plots of SecA, SecAΔMBD and 875 
SecAΔCTT. Representative plot of the thermal denaturation of SecA as determined by CD 876 
spectroscopy. The α-helical content of 2 µM solutions of SecA, SecAΔMBD, and 877 
SecAΔCTT in 10mM potassium phosphate (pH 7.5) was determined by measuring molar 878 
ellipticity at 222 nm while the temperature of the solution was raised from 30 to 50°C. The 879 
TMs listed in Table 1 were determined by van’t Hoff analysis.  880 
 881 
Figure 2—figure supplement 3. Expression of SecA, SecAΔMBD and SecAΔCTT in 882 
strains DRH1119, DRH1120 and DRH1121. Strains DRH1119, DRH1120 and DRH1121 883 
(relevant genotype: MC4100 ΔsecA attλ-placUV5-secA), which produce SecA, SecAΔMBD and 884 
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SecAΔCTT, respectively, were grown in LB in the presence of 100 μM IPTG to mid-log 885 
phase. Cell lysates were normalized to cell density, resolved by SDS-PAGE and probed by 886 
western blotting using antisera against SecA and thioredoxin-1, as a loading control. 887 
 888 
Figure 3—figure supplement 1. Crosslinking of SecABpa399 to RNCs containing arrested 889 
nascent full-length SecM and MBP. 1 μM SecABpa399 was incubated with 1 μM non-890 
translating 70S ribosomes (vacant) or RNCs containing arrested nascent SecM (SecM-RNCs) 891 
or maltose binding protein (MBP-RNCs). Where indicated, samples were exposed to light at 892 
365 nm (UV). Samples were then resolved using SDS-PAGE and probed by western blotting 893 
against SecA. The positions of SecA and the crosslinking adduct between SecA and 894 
ribosomal protein uL29 are indicated.  895 
 896 
Figure 3—figure supplement 2. Crosslinking of SecABpa399 to RNCs containing arrested 897 
nascent chains with different lengths. 1 μM SecABpa399 was incubated with 1 μM non-898 
translating 70S ribosomes (vacant) or RNCs containing arrested nascent SecM, which was 899 
internally truncated between the signal sequence and the translation arrest sequence 900 
(SecM56-RNCs). Previous studies indicate that SecM56 does not promote salt-resistant 901 
binding of SecA to the ribosome (Huber et al. 2017). After incubation, samples were exposed 902 
to light at 365 nm (UV treated) or incubated in the dark (untreated). Samples were then 903 
resolved using SDS-PAGE and probed by western blotting against SecA. The positions of 904 
SecA and the crosslinking adduct between SecA and ribosomal protein uL29 are indicated. 905 
 906 
Figure 4—figure supplement 1. C-terminal purification of SecA-biotin and SecABpa852-907 
biotin by the C-terminal biotin. Lysates of cells producing SecA-biotin (DRH854) or 908 
SecA
Bpa852
-biotin (DRH1166) were incubated in the dark (-) or exposed to light at 365 nm (+) 909 
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for 30 minutes. The biotinylated protein was purified using streptavidin-coated magnetic 910 
beads and resolved on a BioRad Stain-free gel. The position of the faster migrating band that 911 
is isolated by N-terminal affinity purification is indicated (*). An additional high molecular 912 
weight band, which is consistent with the weight of dimeric SecA, is also indicated (**). 913 
 914 
Figure 5—figure supplement 1. SAXS analysis of the solution structure of SecA, 915 
SecAΔMBD and SecAΔCTT. X-ray scattering plots for SecA (black), SecAΔMBD (red) 916 
and SecAΔCTT (green). The region of divergence between the three SAXS traces in the mid-917 
q region is indicated (black arrow). 918 
 919 
Supplementary files 920 
Supplementary file 1. Clustal Omega alignment of SecA proteins used to construct 921 
phylogenetic tree in figure 1. 922 
 923 
Supplementary file 2. Phylogenetic tree data generated by Clustal Omega used to 924 
construct figure 1B and 1C. 925 
 926 
Supplementary file 3. Table of SecA tryptic peptides detected by MALDI-TOF.  927 
 928 
Supplementary file 4. Table of data collection and refinement statistics for the crystal 929 
structure of SecAΔMBD. 930 
 931 
Supplementary file 5. Table of SAXS data collection and processing details for SecA, 932 
SecAΔMBD and SecAΔCTT. 933 
 934 
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Supplementary file 6. Table of fitting parameters of models of the E. coli SecA dimer. 935 
 936 
 937 
 938 
















